why choose us

First received: November 06, 2023

Clinical Trial: Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel

Study Status: Completed

Recruit Status: RECRUITING

Condition: COVID-19

Study Type: INTERVENTIONAL


Official Title: Multi-center Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel

Brief Summary: The study is designed as a prospective, multicentric, clinical study to investigate the positive percent agreement (PPA) and negative percent agreement (NPA) of the Panbio™ COVID-19/Flu A&B Panel using anterior nasal swab specimens tested directly, relative to the comparator methods, Roche cobas® SARS-CoV-2 (K231306) and Quidel Lyra® Influenza A+B Assay(K230236) (RT-PCR) in symptomatic patients suspected of respiratory viral infection by a healthcare provider.

Read more